Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.72 |
| ▸ | RAD52 | P43351 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | DGKA | P23743 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27912518 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL27912427 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5448501 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL27895287 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL4332027 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5696640 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL1548190 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL20067027 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5440890 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH | |
| SCHEMBL5438833 | 1.00 | NAAA (0.72) | NAAARAD52NPSR1DGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1059563-B1 | Agent for reducing substrate dependence of resist | WAKO PURE CHEM IND LTD (JP) | 2006-08-09 | — | — | EP | claimed |
| US-6586152-B1 | Useful as an ingredient of a resist composition used for preparation of semiconductor devices and the like, which comprises a compound shown by the following general formula useful as an ingredient of a resist composition used for | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2003-07-01 | — | — | US | claimed |
| EP-1059563-A1 | Agent for reducing substrate dependence of resist | Wako Pure Chemical Industries, Ltd. (JP) | 2000-12-13 | — | — | EP | claimed |
| US-12624309-B2 | Enol ether properfume | FIRMENICH SA (CH) | 2026-05-12 | — | — | US | disclosed |
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20240351957-A1 | ADMIXTURE TO CONTROL THE HEAT FLOW FROM MINERAL BINDER COMPOSITIONS, MINERAL BINDER COMPOSITIONS, AND PRODUCTION METHOD THEREOF | SIKA TECHNOLOGY AG (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024175602-A1 | LIGHTWEIGHT CEMENTITIOUS COMPOSITION HAVING KINETIC REGULATOR | SIKA TECHNOLOGY AG (CH) | 2024-08-29 | — | — | WO | disclosed |
| WO-2024175610-A1 | METHODS FOR THE APPLICATION IN THICK LAYER OF CEMENTITIOUS COMPOSITIONS COMPRISING KINETIC REGULATOR | SIKA TECHNOLOGY AG (CH) | 2024-08-29 | — | — | WO | disclosed |
| EP-4417587-A1 | METHODS FOR THE APPLICATION IN THICK LAYER OF CEMENTITIOUS COMPOSITIONS COMPRISING KINETIC REGULATOR | Sika Technology AG (CH) | 2024-08-21 | — | — | EP | disclosed |
| EP-4417588-A1 | LIGHTWEIGHT CEMENTITIOUS COMPOSITION HAVING KINETIC REGULATOR | Sika Technology AG (CH) | 2024-08-21 | — | — | EP | disclosed |
| WO-1994004525-A1 | BENZOHETEROCYCLIC COMPOUNDS AS OXYTOCIN AND VASOPRESSIN ANTAGONISTS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-03-03 | — | — | WO | disclosed |
| US-5286865-A | Contain reactive functional group which can be chemically attached to selected polymer substrates | CIBA-GEIGY CORPORATION (US) | 1994-02-15 | — | — | US | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| US-5244898-A | Vasopressin antagonist | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0514667-A1 | Benzazepin derivatives as vasopressin antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-25 | — | — | EP | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| EP-0382185-A2 | Carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4005189-A | Process of suppressing odors employing deodorants containing esters of aliphatic hydroxycarboxylic acids | HENKEL & CIE G.M.B.H. (DT) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | NAAA 757/4885RAD52 1397/4885NPSR1 4881/4885 |
| US-12624309-B2 | Enol ether properfume | CYP2E1, CBR1, ADH5 | NAAA 2097/4885RAD52 3787/4885NPSR1 3997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.